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The inhibitor of monoaminooxydase isatin and the ligand of B-receptors cholecystokinin-
4 play a significant role in the suppression and induction of depressive and anxiety states.
We induced the formation of auto-antibodies to these compounds against their conjugates
with antigen-carrier by immunization of white rats. The result was long-term (more than
2 months) stimulation of depressive and anxiety behavior after immunization to isatin and,
in contrast, the suppression of such behavior after immunization to cholecystokinin. The
perspective of immunochemical approach to long-term correction of behavior is discussed. 
Keywords: Depression, modeling, immuno-correction, active immunization, cholecystokinin-
4, isatin, biogenic amines, rats.
El inhibidor de la monoaminooxidasa isatin y el ligando de B-receptores colecistokinina-
4 juegan un papel significativo en la supresión e inducción de los estados de ansiedad
y depresión. Nosotros hemos inducido la formación de auto-anticuerpos contra estas
sustancias mediante la inmunización de ratas blancas. El resultado fue la estimulación
prolongada (más de 2 meses) de conducta depresiva y de ansiedad tras la inmunización
con isatin y, por el contrario, la supresión de esta conducta después de la inmunización
con colecistokinina. En el artículo se discute la posibilidad de la corrección de la conducta
a largo plazo mediante la manipulación immunoquímica.
Palabras clave: Depresión, remodelación, immuno-corrección, inmunización activa,
colecistokinina-4, isatin, aminas biogénicas, ratas.
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For the comprehension of the pathogenesis of depression
and the search for effective antidepressants, it is important
to acquire the most adequate experimental model of
protracted depression. Existing models, based on
pharmacological action, as well as on electrolytic, surgical,
or ischemic damage to specific brain regions and so on have
one significant shortcoming in the form of their brief
duration. Over the past years, several hypotheses and data
relating to the role of neuroimmunological processes in the
pathogenesis of depression have been presented (Leonard,
2001; Friedman, Becker, Overstreet, & Lawrence, 2002;
Arushanyan & Bayer, 2004). The search for new and more
effective modeling for and suppression of depression has
led us to refer to the method of inverse immunoregulation
(Ashmarin, Danilova, & Obukhova, 2001; Ashmarin &
Gomazkov, 1992; Danilova, & Ashmarin, 1994) consisting
of the induction of the formation of auto-antibodies to
endogenous chemical regulators. If the regulator in question
is a low-molecular compound, immunogenicity is attained
by covalent conjugations with a neutral antigen carrier. The
duration of such induced formation of auto-antibodies in
primary immunization is 3-8 months, and in secondary
immunization – years. 
Important factors limiting the activity of mono-oxidases
and the development of depression are the endogenous
regulators isatin and tribuline (Medvedev & Glover, 2004).
Exogenous analogues of these compounds are antidepressants
such as pargyline, deprenyl, and so on.
Previously, we were able to establish the possibility of
artificially creating protracted depressive states in
experimental animals by the induction of auto-antibodies to
the psycho-stimulant with antidepressive effects sydnophen,
as well as to exogenous inhibitors of monoamine oxidase
(MAO), antidepressants, pargyline, and deprenyl (Ashmarin,
Danilova, Mashkovskii, et al., 1990; Ashmarin, Danilova,
Mel’nik, et al. 1989; Danilova, Belopolskaya, Kushnir,
Moskvitina, et al., 2000; Danilova, Obukhova, Ashmarin,
et al., 1988; Danilova, Obukhova, Belopolskaya, &
Ashmarin, 1998; Danilova, Moskvitina, Obukhova,
Belopolskaya, & Ashmarin, 1999). 
Immunization was accompanied by the formation of
antibodies to pargyline or deprenyl, increased activity of MAO,
and changes in the concentration of biogenic amines. These
biochemical changes correlated with severe and protracted
behavioral changes in rats, indicating the presence of depression
(decreased exploratory activity, increased immobilization period
in the Porsolt test, as well as signs of anxiety). 
In the present study, immunization of rats was attained
using covalent conjugates of the endogenous MAO inhibitor
isatin with an antigen carrier, with consecutive immunologic
and biochemical assays and behavioral analysis.
The effectiveness of the immunochemical approach to
the modeling of depressive states and their duration allows
for the affirmative evaluation of the perspectives of the
present course and the possibility of long-term correction
of pathologicalal states of anxiety and depression. Despite
the availability of a wide range of anxiolytics and
antidepressants, the problem of the correction of pathological
anxiety and depression is far from successful solution. Such
a possibility may have come about following the discovery
of endogenous anxiety factors, the most effective of which
is the tetrapeptide Trp-Met-Asp-Phe-NH2 - cholecystokinine-
4 (CCK-4). As revealed, an anxiogenic effect is noted not
only in CCK-4 itself, but also in its structural analog, CCK-
3 (Met-Asp-Phe-NH2). This fact has served as the basis for
the study of immunological correction of states of anxiety
and phobia based on the immunization of white rats with
conjugates of CCK-4 and CCK-3 with antigen carriers
(Ashmarin, Danilova, Rud’ko, Obukhova, & Andreeva, 2004;
Danilova, & Fedorova, 2001; Danilova, Rud’ko, O.I.,
Korotkova, Obukhova, & Ashmarin, 2002). 
Material and Methods
Subjects
The present study was carried out on white male Wistar
rats weighing 150-180 g at study commencement. The
animals were placed in a vivarium with controlled SPF
conditions: air temperature 22±2º C, relative humidity
50±5%, automatic time-period changes with “daytime” from
8:00 to 20:00 and “night” from 20:00 to 8:00. The rats were
kept in plastic cages (60 × 35 × 20 cm), equipped with steel
latticed lids, feeding niches, and separators with wood filings
as litter for 7-8 rats per cage (no more). Extruded and
balanced mixed fodder PK-120-1 for laboratory rats and
mice (OOO “LABORATORSNAB” GOST P 50258-92) was
provided ad libitum. Water was provided in standard water
bottles with steel nozzles. 
Each series of experiments included no less than 10-12
control and study rats. Each series was repeated 2-3 times.
Procedure
Immunization of rats. Immunization of rats was attained
using the MAO inhibitors isatin and deprenyl (N-dimetyl-
N [2-propyl] benzenethanamine hydrochloride,  ICN
Biomedical Inc., USA), and fragments 30-33 (Trp-Met-Asp-
Phe-NH2) and 31-33 (Met-Asp-Phe-NH2, ICN Biomedical
Inc., USA) of cholecystokinine covalently conjugated the
antigen carrier bovine serum albumin (BSA). The synthesis
of conjugates was carried out using the binding agent
carbodiimide -1 (N-ethyl-N’3-dimethylaminopropyl muriatic
carbodiimide) in molar ratio 1:100.  The immunization of
the rats with the conjugates was carried out three times
subcutaneously at four points of the back with an interval
of 7-8 days; the first two times using Freund’s adjuvant
immunostimulant (ICN Biomedical Inc., USA) in volume
ratio 1:1. Immunization dosage was chosen by calculation
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using 600-800 µg per kilogram mass. The controls were
administered adjuvant with physiological saline solution.
Immunological Assessments. Immunological assessments
of blood serum of the control and study rats were carried
out using ELISA technique; phosphate buffer pH 7.5.
Biochemical Assessments. For the assessment of MAO
activity, mitochondria of the experimental animals were
extracted from their livers and brains by differential centrifuge
in a 0.25 M sucrose solution. MAO activity was measured
according to the accumulation of tainted product (450 nm)
in the oxidation of p-nitrophenylethylamine at 25°C. The
reaction composite consisted of 950 µl of 50 mM phosphate
buffer, pH 7.4, 25 mg tritone X-100, 50 µl mitochondria
suspension and 0.1 mM p-nitrophenylethylamine. Alteration
of the absorption at 0.01 corresponded to 0.33 nmole NH4+.
The concentration of monoamines and their metabolites
in the striatum was assessed using the method of high-
performance liquid chromatography with electrochemical
detection. 
Behavioral Testing. Behavioral testing was carried out
3-4 weeks following immunization and later (after 2-2.5
months) with the following tests.
1. Rat motor and orientation-exploratory activity with
the registration of horizontal and vertical components
was assessed using the automatic apparatus
“RODEO.” This apparatus is a darkened chamber (50
× 50 × 20 cm) with 16 apertures (diameter 3.5 cm)
at its base and 25 on its lid. With the aid of light
sensors in the chamber, automatic registration of the
parameters of horizontal activity (in conditional units),
the quantity of vertical stance, and the quantity of
explored upper and lower burrows was conducted.
The total test period was either 5 or 10 minutes. 
2. Anxiety components and fear in the rats’ behavior
was assessed using an elevated cross maze. The maze
was made up of a cross platform elevated above the
floor on a central mount at a height of 80 cm with
four perpendicular beams 10 cm wide and 45 cm long,
at the intersection of which there is a central open
platform 10 × 10 cm. One pair of opposite beams has
3 opaque flanks and the other pair of beams is
transparent. The rats were placed at the center of the
maze facing the transparent beam. Visual registration
of indices such as exits to the open beams, the time
spent in them, total number of transitions, risk
behavior, quantity of stances, freezing time, latent
period before motion commencement, first entry to
the dark chamber, and the amount of defecations were
carried out during a period of 5 minutes.
3. For the identification of anxiety components, the
“light/dark” test was used. The animals were placed
in a box divided into two compartments by an opaque
partition (dimensions, 20 × 20 cm). One compartment
was illuminated, the other dark. The rats were able
to move freely between compartments.  The rats were
placed in the illuminated compartment and the latent
period of movement to the dark compartment was
registered. Further, the quantity of transitions from
the illuminated compartment to the dark compartment
and the total time in the illuminated compartment was
assessed. The total testing time comprised 5 minutes.  
4. The disposition of the rats to the development of
depression-like states was assessed using Porsolt’s
method in the test of unavoidable swimming. The rats
were placed in a semitransparent plastic tank 45 cm
high filled up to 30 cm with water of 20-21ºC. Using
a computer program, the duration of protracted active
(vigorous movements in all extremities) and passive
(feeble paddling in the hind paws) swimming and
immobility was registered for 10 minutes. 
Statistical Analysis 
Statistical analysis of the acquired data was carried out
using Wilcoxon-Mann-Whitney U-criteria and statistical
computer software Excel and Statistica.
Results
Results of Isatin BSA Conjugate Immunization 
Immunological effects. Immunization with isatin BSA
conjugate led to the formation of a significant and persistent
concentration of antibodies to isatin with mean titer 1:12800
(control titer, 1:160). As shown in Table 1, the antibody
titer in immunization to isatin is higher than immunization
to the exogenous regulator deprenyl. The difference in titer
in the control and study groups was statistically significant
(p < .001).
IMMUNOCHEMICAL MODEL AND LONG-TERM SUPPRESSION OF DEPRESSIVE AND ANXIETY BEHAVIOR 221
Table 1
Inmunological Assessment Indexes
Antibody Titer
Groups
Deprenyl Isatin
Controls:  n = 40 1:160 1:160
Deprenyl Immunization Group:  n = 25 1:6400 1:6400
Isatin Immunization Group:  n = 25 1:12800 1:12800
The results of cross reaction provide evidence of the fact
that all deprenyl antibodies were significantly reactive to
isatin and vice versa, all isatin antibodies reacted with
deprenyl. 
Biochemical effects. Data represented in Table 2 show
the statistically significant increase in MAO activity in the
immunized rats’ brains and, furthermore, this increase in
rats immunized with isatin was more pronounced than in
rats immunized with deprenyl.
A consequence of the alteration in MAO activity is the
statistically significant decrease in serotonin and the
concentration of its metabolites in the brain striatum.
Furthermore, dopamine concentration remained at the same
concentration as in controls, although the concentration of
its metabolites increased (see Figure 1).
Behavioral effects of immunization. The results of the
unavoidable swimming test used for the assessment of
depressive components in animal behavior are presented in
Table 3. 
As is evident, rats immunized with isatin conjugates
revealed a significant decrease in active swimming time (p
< .001) in comparison to controls and, most importantly,
there was a significant increase in time of immobility (p <
.001). Results of the unavoidable swimming test carried out
twice (the first 3-4 weeks after immunization and at later
stages, 2-2.5 months after immunization) in one series with
rats immunized with a conjugate of endogenous MAO
inhibitor isatin and exogenous inhibitor deprenyl showed
the development of more severe depression of behavioral
activity following immunization with isatin (see Figure 2). 
ASHMARIN, DANILOVA, RUD’KO, BELOPOLSKAYA, OBUKHOVA, AND SHMALGAUSEN222
Table 2
MAO Activity (Nmole Nh4+/Min) after Immunization with Deprenyl and Isatin Conjugates
Groups Liver Brain
Controls: n = 10 0.166 + 0.015 0.1 + 0.02
Deprenyl:  n = 10 0.192 ± 0.007 (116%) 0.153 ± 0.011 (153%)*
Isatin:  n = 10 0.145 ± 0.009 (87.3%) 0.186 ±0.02 (186%)**
*p < .05. **p < .01. 
Table 3
Unavoidable Swimming Test Indexes in Rats Immunized with Isatin Conjugate
Groups                                     Active swimming Passive swimming Immobility
Controls: n = 20 142.9 ± 15.3 s 379.6 ± 26.5 s 77.6 ±9.3 s
Isatin: n = 20 77.32 ± 9.8 s*** 330.4 ± 23.4 s 192.5 ±14.6 s***
***p < .001.
Figure 1. Biochemical changes in rat brain striatum following
immunization with isatin BSA conjugate (% of control). 
Controls: n = 12; study group: n = 12
Statistical significance (Wilcoxon-Mann-Whitney U-criteria): *p
< .05. **p < .01. 
Figure 2. Indices of unavoidable swimming following immunization
of rats with deprenyl and isatin conjugates (% of control): 1 = time
of active swimming; 2 = immobility period.  Controls:  n = 20;
deprenyl immunization: n = 20; Isatin immunization:  n = 20.
Statistical significance (Wilcoxon-Mann-Whitney U-criteria): *p
< .05. **p < .01. 
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Testing the rats in the cruciform maze showed a decrease
in the amount of total transitions, a significant increase in
latent period of motion initiation (231% of controls, p <
.05) and immobility period (147.4% of controls, p < .05),
which may indicate a decrease in orientation-exploratory
activity in the maze. It is important that in the automated
open field, no decrease in motor activity was noted.
Furthermore, immunized rats in the maze showed changes
in indices of anxiety and fear components, that is, a decrease
in exits to open beams and time spent in them (40 and 16.9%
accordingly of controls), and an increase in the amount of
defecation. During the period spent within the cruciform
maze, some rats showed pronounced anxiety and fear
reactions such as agitation, turning, moving backwards. 
The use of the antidepressant fluoxetine for the alleviation
of depressive components showed that acute administration
of fluoxetine to rats immunized with deprenyl and isatin (20
mg/kg thrice daily) led to the increase in active swimming
time practically to the level of controls (see Figure 3). However,
immobility period remained unchanged. Chronic administration
of fluoxetine (during 1 week) not only increased the period
of active swimming but also decreased the time of immobility,
although these changes did not reach significance. The partial
alleviation of depressive symptoms with fluoxetine in rats in
particular, demonstrated the extent and stability of the
depressive effect of immunization with MAO inhibitors.
Results of Rat Immunization with Cholecystokinine-4
BSA Conjugate
Behavioral effects. As opposed to immunization with
MAO inhibitors, immunization to the anxiety factor CCK-
4 and its structural analogue CCK-3 led to the completely
opposite effects. In the test of unavoidable swimming in
immunized rats, the indices were directly opposite: The time
of active swimming increased in comparison to controls and
the time of immobility significantly decreased (see Table 4).
Testing in the cruciform maze also showed several
behavioral changes, bearing evidence not only of the absence
of anxiety and fear components noted in rats immunized with
MAO inhibitors, but also of a decrease in anxiety of the
immunized animals in comparison to controls (see Figure 4).
There was an increase in the number of exits to the open
sectors and time spent within them, risk behavior, and
exploratory activity, and a decrease in the time of freezing in
comparison to controls. Behavioral changes in immunized rats
in the automated open field showed a stimulatory effect of
immunization on motor and orientation-exploratory activity.
As of the 5th minute, when the activity of control rats
decreased, the immunized animals showed a high level of
motor and orientation-exploratory activity (see Figure 5). Using
the “light/dark” test, we observed an increase in the amount
of exits of the immunized rats to the illuminated compartment
and the time spent in it in comparison with controls (see Table
5), which also reveals the anxiolytic effect of immunization.
Figure 3. The influence of fluoxetine on the indices of active swimming
in control rats (1), isatin conjugate immunized rats (2), and deprenyl
conjugate immunized rats (3). Light bars = indices of the groups prior
to administration; dark bars = following fluoxetine administration.
Number of rats in each group: n = 10
Statistical significance (Wilcoxon-Mann-Whitney U-criteria: *p < .05. 
Table 5
Behavior Indices of Rats Immunized with CCK-3 and CCK-4 in the “Light/Dark” Test 
Groups                               Number of Exits to Illuminated Compartment     Time Spent in Illuminated Compartment (in seconds)
Controls 2.00 ± 0.51 24.10 ± 6.56
Immunized with CCK-3 3.63 ± 1.04* 41.25 ± 14.52*
Immunized with CCK-4 3.60 ± 1.10** 33.10 ± 12.20
*p < .05. **p < .01. *p < .05. **p < .01. 
Table 4
Unavoidable Swimming Test Indexes Following Immunization with CCK-4 BSA Conjugate
Groups                                     Active swimming Passive swimming Immobility
Controls: n = 20 121.80 ± 19.52 s 313.29 ± 25.34 s 170.36 ± 24.75 s
CCK-4: n = 20 183.45 ± 17.23 s* 350.35 ± 27.32 s 56.20 ± 10.26 s***
*p < .05. *** p < .001.
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Figure 4. Behavior of rats immunized with CCK-4 conjugate in the “plus” maze (% of control). 
A. Indices characterizing anxiolytic effect: 1= number of exits to open beams; 2 = time in open beams; 3 = ratio open/closed exits; 4 =
time in closed beams; 5 = risk behavior.  
B. Indices of orientation-exploratory activity: 1 = number of peeps into open beams; 2 = number of entries into closed beams; 3 = total
number of transition;4 = freezing time. Control: n = 30; study group: n = 30.
Statistical significance (Wilcoxon-Mann-Whitney U-criteria): *p < .05. **p < .01. ***p < .005.
Figure 5. Changes in motor and orientation-exploratory activity in rats immunized with CCK-4 BSA conjugate (% of control group). 
A = number of peeps into upper burrows; C = number of stances; B = number of peeps into lower burrows; D = horizontal activity.
Control: n = 10.
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Thus, immunization with CCK-4 (and CCK-3) rendered
an anxiolytic and antidepressive effect. It should be noted
that the anxiolytic effect was observed not only in the usual
selection of rats, but also in the rats selected with an initially
high level of anxiety. Prior to immunization, a large group
of rats was tested in the cruciform maze, according to the
results of which rats with a high level of initial anxiety were
chosen, and then used for immunization. The acquired data
reveals the importance of the use of such an approach for
the correction of the pathological manifestations of anxiety. 
Immunological and biochemical effects. Immunological
assessments of blood plasma of immunized rats showed a
slight, but statistically significant, concentration of antibodies
to CCK-4 (1/3200-1/6400). Biochemical analysis of the brain
striatum of rats immunized with CCK-4 and BSA conjugate
revealed several changes in the concentration of biogenic
amines. As shown in Figure 6, there was a statistically
significant increase in DA concentration, and decreases in
DA metabolite HVA and HVA/DA and DOPAK/DA ratios.
The concentration of 5-HT remained unaltered.  The
biochemical changes after CCK-4 immunization as well as
behavioral changes are opposite to those resulting form MAO
inhibitor immunization.
Discussion
The present study shows that the induction of auto-
antibodies following the active immunization of rats with
endogenous (isatin) and some exogenous (pargyline,
deprenyl) monoamine oxidase inhibitors leads to a depressed
state with elements of anxiety in experimental animals. The
duration of depression symptoms in the animals exceeds 2
months. 
The modeling of depression in white rats using isatin
immunization is prospective as, firstly, a compound identical
to the endogenous regulator is used; secondly, the effect is
achieved with minimal intervention; and thirdly, a long
duration of model effect is achieved. At the same time, not
only the similarity to anxiety depression in man is achieved,
but also a great correspondence to contemporary theories
of the mechanisms of depression. In combination with the
duration of effect, all these facts determine the advantages
of the suggested model over other methods described. 
In relation to the effectiveness of the model in terms of
trials of known antidepressants, the above described effect
of fluoxetine is the first positive demonstration of its kind,
although the expediency of the widespread approbation of
other antidepressants is obvious.
At the same time, various studies have shown that
psychiatric patients show significant levels of antibodies to
several brain antigens and haptens.  The induction of
antibodies to serotonin and dopamine in rats with an
experimental dopamine-deficit-related depression syndrome
has been demonstrated (Kryzhanovsky, Man’kovsky,
Karaban’, et al., 1994). It is probable that one of the leading
causes of protracted depressive states may be an autoimmune
process, and specifically, the formation of auto-antibodies
to the endogenous MAO inhibitor isatin or isatin containing
tribuline. The protracted circulation of such antibodies leads
to an annihilation of the inhibitory effect of isatin on MAO
and the increased decomposition of serotonin and dopamine.
The penetration of antibodies through the hematoencephalic
barrier under conditions of protracted circulation of these
antibodies has been demonstrated (Burlet, Leon-Henri,
Robert, Arachmani, et al., 1987; Banks & Kastin, 1987,
1988, 1990; Meeker, Meeker, & Hayward, 1987; Poduslo,
Curran, & Berg, 1994; Relber, Kitze, Link, & Wagner, 1988).
A decrease in the concentration of serotonin and
dopamine is a well known factor for the development of
depression. Confirmation of this are the biochemical changes
in the brain revealed in this study. It is possible that the
level of isatin antibodies may be used to assess the severity
of depression and/or latent depression.
On the other hand, induction of protracted depression
by immunization with MAO inhibitors pargyline, deprenyl
and in particular, isatin, is of interest for the treatment of
maniacal and aggressive states.
The immunization with conjugated CCK-4 (peptides
inducing fear, panic states, and depressive behavior in
animals and, in particular, man) that we have demonstrated,
accompanied by the formation of antibodies to CCK-4 and
caused effects opposite to those of CCK-4. It allows the
positive assessment of the prospects of the present direction
for immuno-correction of depression and anxiety.  
The immunological approach to long-term correction of
some pathophysiological states is already in practice
(Stevens, 1996) or is at the stage of preclinical trials (Kosten,
Rosen, Bond, Settles, Roberts, et al., 2002). However, while
assessing the possibilities of the present approach for
practical correction of depression and anxiety, it is important
to consider the very high complexity of these diseases.
Figure 6. Biochemical changes in rat brain striatum following
immunization with CCK-4 BSA conjugate (% of control). 
Control group: n = 12; study group:  n = 12.
Statistical significance (Wilcoxon-Mann-Whitney U-criteria): *p
< .05. **p < .01.
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